MAPK8 and neoplasm: The study presented compelling evidence that pharmacologically inhibiting c-Jun using a Jun amino-terminal kinase (JNK) inhibitor called JNK-IN-8 effectively suppressed tumor growth and bone metastasis in MCF7-BM cells.